Director equity grant at Orthofix Medical (OFIX) totals 14,965 units
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Orthofix Medical Inc. director Alan Lee Bazaar received an equity award of 14,965 deferred stock units of common stock. The units were granted at no cash cost and will vest in full on the first anniversary of the grant date, conditioned on continued board service.
After this grant, Bazaar holds 65,489 shares and units in total, including 42,929 previously reported deferred stock units and 700 shares acquired under Orthofix’s Stock Purchase Plan. Each deferred stock unit represents the right to receive one share of common stock, which will settle within 45 days after his service with Orthofix ends.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Bazaar Alan Lee
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 14,965 | $0.00 | -- |
Holdings After Transaction:
Common Stock — 65,489 shares (Direct, null)
Footnotes (1)
- Represents an award of deferred stock units that vest in full on the first anniversary of the grant date, subject to the reporting person's service through such date. Each deferred stock unit represents a contingent right to receive one share of common stock of the issuer. Vested deferred stock units will settle and convert into common stock within 45 days of the reporting person's termination of service with the issuer. Includes 42,929 previously reported deferred stock units and an aggregate of 700 shares acquired under Orthofix's Stock Purchase Plan ("Orthofix's SPP") on 10/31/2025 and 4/30/2026. Orthofix's SPP is a "Stock Purchase Plan" as defined in Rule 16b-3(b)(5), and share acquisitions under the plan are exempt from Section 16(b).
Key Figures
Deferred stock units granted: 14,965 units
Total holdings after grant: 65,489 shares and units
Previously reported deferred stock units: 42,929 units
+3 more
6 metrics
Deferred stock units granted
14,965 units
Award of deferred stock units on 2026-06-10
Total holdings after grant
65,489 shares and units
Common stock and deferred stock units following transaction
Previously reported deferred stock units
42,929 units
Deferred stock units held before new award
Shares from Stock Purchase Plan
700 shares
Acquired under Orthofix’s Stock Purchase Plan on 10/31/2025 and 4/30/2026
Vesting schedule
1-year cliff
Deferred stock units vest on first anniversary of grant date
Settlement window
Within 45 days
Units settle into stock within 45 days after termination of service
Key Terms
deferred stock units, Stock Purchase Plan, Rule 16b-3(b)(5), Section 16(b)
4 terms
deferred stock units financial
"Represents an award of deferred stock units that vest in full on the first anniversary"
Deferred stock units are promises from a company to give an employee shares of stock at a future date, often after certain conditions are met or after leaving the company. They function like a form of delayed compensation, allowing employees to earn shares over time. For investors, they represent potential future ownership in the company, but do not provide immediate voting rights or dividends until the shares are actually received.
Stock Purchase Plan financial
"Includes 42,929 previously reported deferred stock units and an aggregate of 700 shares acquired under Orthofix's Stock Purchase Plan"
A stock purchase plan is a company-run program that lets employees or qualifying investors buy the company’s shares regularly, often through paycheck deductions and sometimes at a discounted price or with matching contributions. It matters because it encourages ownership—like a workplace discount for buying company products—aligning interests between holders and managers, while affecting share supply and potential value for outside investors.
Rule 16b-3(b)(5) regulatory
"Orthofix's SPP is a "Stock Purchase Plan" as defined in Rule 16b-3(b)(5)"
Section 16(b) regulatory
"share acquisitions under the plan are exempt from Section 16(b)"
A federal rule that requires company insiders—like officers, directors and large shareholders—to return any profits made from buying and selling the company’s stock within a six-month window. It matters to investors because it discourages short-term trades that could exploit non-public information and helps protect outside shareholders by creating a simple, enforceable way to recover unfair gains, much like a rule stopping someone from flipping a limited-edition item for quick profit after getting early access.
